-+ 0.00%
-+ 0.00%
-+ 0.00%

Hengrui Pharmaceutical announced that recently, the company received a notice from the State Drug Administration to approve the addition of two additional indications for the Class 1 innovative drug Hetrapoethanolamine tablets independently developed by the company.

Zhitongcaijing·09/10/2026 09:41:14
Listen to the news
Hengrui Pharmaceutical announced that recently, the company received a notice from the State Drug Administration to approve the addition of two additional indications for the Class 1 innovative drug Hetrapoethanolamine tablets independently developed by the company.